Aditxt, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Aditxt, Inc. (ADTX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$35.17 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-05-20
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$35.17M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.95M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$8.86M.
- 2025-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $13.35M; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed $11.99M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-03-31 | -$35.17M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $3.95M 10-Q · filed 2026-05-20 | |
| 2025-09-30 | -$8.86M 10-Q · filed 2025-11-18 | |
| 2025-06-30 | $13.35M 10-Q · filed 2025-11-18 | $11.99M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $17.12M 10-Q · filed 2026-05-20 | $15.76M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $1.09M 10-Q · filed 2026-05-20 | -$86.60K 10-K · filed 2025-03-31 |
| 2024-09-30 | $4.45M 10-Q · filed 2025-11-18 | |
| 2024-06-30 | $6.34M 10-Q · filed 2025-11-18 | |
| 2024-03-31 | $9.78M 10-Q · filed 2025-11-18 | |
| 2023-12-31 | $16.05M 10-K · filed 2026-03-31 | $16.05M 10-K · filed 2024-04-16 |
| 2023-09-30 | -$4.22M 10-Q · filed 2024-11-18 | |
| 2023-06-30 | -$3.87M 10-Q · filed 2024-11-18 | |
| 2023-03-31 | $68.07K 10-Q · filed 2024-11-18 | |
| 2022-12-31 | $5.21M 10-K · filed 2025-03-31 | |
| 2021-12-31 | $10.18M 10-K · filed 2024-04-16 | |
| 2020-09-30 | $13.75M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | -$3.71M 10-Q · filed 2020-08-13 | |
| 2019-12-31 | -$2.85M 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |